Fresenius 腹膜透析液因主袋微孔泄漏风险自主召回,FDA 记录 D-0170-2027 定为 Class II
FDA drug enforcement D-0170-2027: Fresenius Medical Care Renal Therapies Group, LLC — Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
FDA 执法报告记录 Fresenius Medical Care 肾治疗集团自主召回 DELFLEX 2.5% 葡萄糖低镁低钙腹膜透析液,召回编号 D-0170-2027,定为 Class II。
记录列出泄漏投诉所涉腹膜透析液的具体批号、数量与分销范围,可供核对本次召回边界与无菌保证问题的关联。
FDA drug recall enforcement report — D-0170-2027
Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "350 Merrimack St",
"address_2": "",
"center_classification_date": "20261103",
"city": "Lawrence",
"classification": "Class II",
"code_info": "Lot#: 25JGPD069, Exp 1/31/2027; 25SGPD046, 25SGPD059, 25SGPD063, Exp 6/30/2027; 26EGPD022, Exp 11/30/2027.",
"country": "United States",
"distribution_pattern": "Nationwide in the USA.",
"event_id": "100130",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {
"application_number": [
"NDA020171"
],
"brand_name": [
"DELFLEX"
],
"generic_name": [
"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Fresenius Medical Care de Mexico, S.A. de C.V."
],
"package_ndc": [
"46163-209-92",
"46163-209-94",
"46163-209-95",
"46163-212-95",
"46163-212-92",
"46163-212-94",
"46163-206-92",
"46163-206-94",
"46163-206-95"
],
"product_ndc": [
"46163-206",
"46163-209",
"46163-212"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"INTRAPERITONEAL"
],
"spl_id": [
"5f14959c-adcd-923c-e063-6294a90ab6de"
],
"spl_set_id": [
"a98facd6-9daa-4d37-8209-63a0599dbfaa"
],
"substance_name": [
"DEXTROSE MONOHYDRATE",
"SODIUM CHLORIDE",
"SODIUM LACTATE",
"CALCIUM CHLORIDE",
"MAGNESIUM CHLORIDE"
],
"unii": [
"TU7HW0W0QT",
"LX22YL083G",
"02F3473H9O",
"451W47IQ8X",
"M4I0D6VV5M"
]
},
"postal_code": "01843-1748",
"product_description": "DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay\"safe Exchange Set, 2,500 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT. NO. 054-25322. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-209-94",
"product_quantity": "2,709 cases (5 bags per case)",
"product_type": "Drugs",
"reason_for_recall": "Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.",
"recall_initiation_date": "20261014",
"recall_number": "D-0170-2027",
"recalling_firm": "Fresenius Medical Care Renal Therapies Group, LLC",
"report_date": "20261111",
"state": "MA",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov